Literature DB >> 29318960

The Role of Inflammation in Epicardial Adipose Tissue in Heart Diseases.

Zdenek Matloch1,2, Anna Cinkajzlova3,4, Milos Mraz5, Martin Haluzik3,4,5.   

Abstract

Epicardial adipose tissue is not only a specific adipose tissue depot but also an active endocrine organ producing numerous substances with an important role in the development of obesity-related heart diseases. It is located between myocardium and visceral pericardium and consists predominantly of adipocytes, immunocompetent cells, ganglia and interconnecting nerve branches. Several studies documented a positive correlation between pericardial and epicardial fat and left ventricular hypertrophy and septal thickening, leading to diastolic dysfunction, electrocardiographic abnormalities and facilitating cardiac failure. The cellular cross-talks between epicardial fat and myocardium may include both the vasocrine and the paracrine mechanisms. Adipokines secreted from epicardial adipose tissue, vascular and stromal cells diffuse into interstitial fluid crossing the adventitia, media and intima and modulate cardiac function and cardiomyocyte phenotype and survival. In this article, we review the significance of epicardial adipose tissue and its association with cardiovascular diseases, cellular interactions between epicardial fat and myocardium, secretions of adipokines and inflammatory mediators and a potential of epicardial fat as a therapeutic target for the prevention of obesity-related heart diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Epicardial adipose tissue; adipokines; cardiovascular risk; cytokines; diabetes mellitus; inflammation; obesity.

Mesh:

Year:  2018        PMID: 29318960     DOI: 10.2174/1381612824666180110102125

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  ANGPTL4 Expression Is Increased in Epicardial Adipose Tissue of Patients with Coronary Artery Disease.

Authors:  Yasufumi Katanasaka; Ayumi Saito; Yoichi Sunagawa; Nurmila Sari; Masafumi Funamoto; Satoshi Shimizu; Kana Shimizu; Takehide Akimoto; Chikara Ueki; Mitsuru Kitano; Koji Hasegawa; Genichi Sakaguchi; Tatsuya Morimoto
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

2.  Increased Number of Mast Cells in Epicardial Adipose Tissue of Cardiac Surgery Patients With Coronary Artery Disease.

Authors:  K Rozsívalová; A Pierzynová; H Kratochvílová; J Lindner; M Lipš; T Kotulák; P Ivák; I Netuka; M Haluzík; T Kučera
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

3.  Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention.

Authors:  Changqing Lu; Helei Jia; Zhentao Wang
Journal:  Biosci Rep       Date:  2019-05-07       Impact factor: 3.840

4.  Decreased Epicardial CTRP3 mRNA Levels in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease Undergoing Elective Cardiac Surgery: A Possible Association with Coronary Atherosclerosis.

Authors:  Zdenek Matloch; Milos Mraz; Barbora Judita Kasperova; Helena Kratochvilova; Petr Svoboda; Iveta Pleyerova; Katerina Reznickova; Sarah Norman; Daniel Hlavacek; Jakub Mahrik; Peter Ivak; Zdenka Lacinova; Ivan Netuka; Martin Haluzik
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 5.  Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders.

Authors:  Elena Vianello; Marta Kalousová; Elena Dozio; Lorenza Tacchini; Tomáš Zima; Massimiliano Marco Corsi Romanelli
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.